INTRODUCTION AND OBJECTIVES: Castration-resistant prostate cancer (CRPC) has been leading cause of prostate cancerrelated death at present. Therefore, improved therapeutic options are needed for men with CRPC and the mechanism of tumor progression and drug resistance should be elucidated. We have found that galectin-3 enhances anti-cancer drug resistance induced by cisplatin or etoposide through the regulation of caspase signaling in prostate cancer. Here, we investigate the effects of galectin-3 for taxane chemotherapy and new promising drug PARP inhibitor in CRPC. We also investigate the tumor progression and drug resistance mechanisms of galectin-3 for CRPC using bioinformatics analysis.
INTRODUCTION AND OBJECTIVES: Wnt signaling has been implicated as a driver of prostate cancer related osteoblast differentiation, and previous studies have linked modifications in Wnt function with the induction of tumor metastasis. A unique aspect of prostate cancer bone metastases is their relative predilection to the lower compared to upper extremity. We sought to better understand this phenomenon, focusing on the role of the Wnt signaling pathway as an important driver of prostate cancer bone metastasis.
METHODS: Comparative gene expression profiling was performed within the humerus and femur of mice to assess for baseline differences in the microenvironments of these locations. Specifically, RNA was isolated from bone marrow cells from sites of prostate cancer metastases in the mouse humerus and femur, and a gene expression microarray was used to identify differentially expressed genes between these sites. In vitro studies using LNCaP and PC3 cell lines included shRNA knockdown targeting Wnt signaling and conditioned media experiments with and without Wnt inhibition.
RESULTS: Relative overexpression of Wnt signaling inhibitors WIF1 and SOST was seen in the humerus compared to the femur, with increased WNT5a expression in femur bone marrow, suggesting a coordinated upregulation of Wnt signals within the femur relative to the humerus. Conditioned medium (CM) from bone marrow stromal cells (HS-5) was used to mimic the bone marrow microenvironment, which showed a strong ability to promote prostate cancer cell invasion (3.3 fold increase in PC3 cells, p<0.05; 7 fold increase in LNCaP cells, p<0.05). shRNA mediated WNT5a suppression within the CM significantly reduced PC3 (56%, p<0.05) and LNCaP (60%, p<0.05) cell invasion. Similarly, pre-incubation of CM with WIF1 significantly blocked LNCaP cell invasion (40%, p<0.05). shRNA mediated knockdown of Wnt receptors FZD4 and FZD8 also strongly inhibited tumor cell invasion (60% inhibition for shFZD4, p<0.05; 63% for shFZD8, p<0.05), suggesting that Wnt signaling factors at least partially mediate prostate cancer spread within bone.
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